AVXS


AveXis (AVXS) Takeover Validates the Paradigm-Shifting Nature of AVXS-101, Says William Blair

It’s a big day for AveXis (NASDAQ:AVXS). The drug maker has reached an agreement to be acquired by Novartis (NASDAQ:NVS) for $8.

Here’s Why AveXis (AVXS) Investors Are Celebrating Today

AveXis (NASDAQ:AVXS) investors are busy throwing a party today following the news that Novartis (NYSE:NVS) has reached an agreement to acquire AveXis for …

Chardan Bullish on AveXis Inc (AVXS) Following Rival Spinraza Broad-Label Approval

Chardan analyst Gbola Amusa is placing his confidence behind AveXis Inc (NASDAQ:AVXS) even in light of competitors Biogen Inc (NASDAQ:BIIB) and Ionis Pharmaceuticals …

Citron Research Cautious on AVX Corporation (AVXS); Sees at Least 43% Downside

Rarely in biotech do we see a situation where an investor can simply perform their own due diligence and be on the right …

Analysts Weigh in on Three Rising Healthcare Stocks: Palatin Technologies, Inc. (PTN), Novocure Ltd (NVCR) and AveXis Inc (AVXS)

Healthcare stocks Palatin Technologies (NYSEMKT:PTN), Novocure Ltd (NASDAQ:NVCR), and AveXis Inc (NASDAQ:AVXS) are reaping the benefits of clinical and corporate progress updates that have sent the …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts